Researchers in the Division of Rheumatology conduct and participate in a number of clinical studies in the below areas.
Antiphospholipid Syndrome (APS)
Please visit the Clinical Trials & Research Studies page on Dr. Jason Knight's lab website.
REduCing Immunogenicity to PegloticasE (RECIPE) Study
This trial is a multi-site proof-of-concept study in participants initiating Pegloticase for treatment of chronic refractory gout. The goal is to determine whether a short course of immune modulating therapy with Mycophenolate Mofetil (MMF) can significantly and safely attenuate immunogenicity to Pegloticase and ensure patients afflicted with chronic refractory gout have better treatment outcomes and improved quality of life.
Principal Investigator: Puja Khanna, MD, MPH
Please visit the Research Opportunities page on the Scleroderma Program website.